• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多结节性肝细胞癌微血管侵犯的术前预测因子。

Preoperative predictors of microvascular invasion in multinodular hepatocellular carcinoma.

机构信息

Department of Hepatobiliary Surgery, PLA Navy General Hospital, No. 6 Fucheng Road, Beijing 100048, China.

出版信息

Eur J Surg Oncol. 2013 Aug;39(8):858-64. doi: 10.1016/j.ejso.2013.04.003. Epub 2013 May 11.

DOI:10.1016/j.ejso.2013.04.003
PMID:23669199
Abstract

BACKGROUND

The preoperative predictors of microvascular invasion (MVI) in multinodular hepatocellular carcinoma (HCC) are currently unclear.

METHODS

We retrospectively analyzed 266 patients who underwent potentially curative resection of multinodular HCC. MVI was diagnosed on pathological examination in 64 patients. Preoperative risk factors for MVI were identified and survival curves were analyzed.

RESULTS

Patients with MVI had significantly lower overall and recurrence-free survival rates than those without MVI (overall survival, 1 year: 86% vs. 71%, 3 years: 58% vs. 16%; recurrence-free survival, 1 year: 69% vs. 12%; 3 years: 48% vs. 12%; both P < 0.001). Multivariate analysis showed that serum alpha-fetoprotein (AFP) level >400 μg/L (odds ratio [OR] = 3.732, P = 0.016), serum gamma-glutamyltransferase (GGT) level >130 U/L (OR = 19.779, P < 0.001), total tumor diameter >8 cm (OR = 5.545, P = 0.010), and tumor number >3 (OR = 11.566, P = 0.007) were independent predictors of MVI. A scoring system was constructed, and the MVI rate was significantly higher in patients with a score of ≥3 than those with a score of <3 (64.1% vs. 10.9%, P < 0.001). Overall and recurrence-free survival rates were significantly lower in patients with a score of ≥3 (both P < 0.001).

CONCLUSIONS

Serum AFP level >400 μg/L, serum GGT level >130 U/L, total tumor diameter >8 cm, and tumor number >3 were preoperative predictors of MVI in patients with multinodular HCC. In patients with a high risk of MVI and well-preserved liver function, anatomic resection may be worth considering.

摘要

背景

目前尚不清楚多结节性肝细胞癌(HCC)中微血管侵犯(MVI)的术前预测因素。

方法

我们回顾性分析了 266 例接受多结节性 HCC 根治性切除术的患者。64 例患者的 MVI 经病理检查诊断。确定 MVI 的术前危险因素,并分析生存曲线。

结果

MVI 患者的总生存率和无复发生存率明显低于无 MVI 患者(总生存率:1 年为 86%比 71%,3 年为 58%比 16%;无复发生存率:1 年为 69%比 12%,3 年为 48%比 12%;均 P<0.001)。多变量分析显示,血清甲胎蛋白(AFP)水平>400μg/L(比值比[OR] = 3.732,P = 0.016)、血清γ-谷氨酰转肽酶(GGT)水平>130 U/L(OR = 19.779,P<0.001)、肿瘤总直径>8cm(OR = 5.545,P = 0.010)和肿瘤数目>3 个(OR = 11.566,P = 0.007)是 MVI 的独立预测因素。构建了评分系统,评分≥3 分的患者 MVI 发生率明显高于评分<3 分的患者(64.1%比 10.9%,P<0.001)。评分≥3 分的患者总生存率和无复发生存率明显较低(均 P<0.001)。

结论

血清 AFP 水平>400μg/L、血清 GGT 水平>130 U/L、肿瘤总直径>8cm、肿瘤数目>3 个是多结节性 HCC 患者 MVI 的术前预测因素。对于 MVI 风险高且肝功能良好的患者,解剖性切除术可能值得考虑。

相似文献

1
Preoperative predictors of microvascular invasion in multinodular hepatocellular carcinoma.多结节性肝细胞癌微血管侵犯的术前预测因子。
Eur J Surg Oncol. 2013 Aug;39(8):858-64. doi: 10.1016/j.ejso.2013.04.003. Epub 2013 May 11.
2
Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma.肝癌切除术前行微血管侵犯预测。
J Surg Oncol. 2010 Oct 1;102(5):462-8. doi: 10.1002/jso.21631.
3
Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.肝细胞癌患者的微血管侵犯及其可预测的临床病理因素。
Ann Surg Oncol. 2008 May;15(5):1375-82. doi: 10.1245/s10434-008-9846-9. Epub 2008 Mar 7.
4
A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma.计算机断层扫描放射基因组生物标志物可预测肝细胞癌的微血管侵犯和临床结局。
Hepatology. 2015 Sep;62(3):792-800. doi: 10.1002/hep.27877. Epub 2015 Jul 1.
5
The significance of classifying microvascular invasion in patients with hepatocellular carcinoma.肝细胞癌患者微血管侵犯的分类意义。
Ann Surg Oncol. 2014 Mar;21(3):1002-9. doi: 10.1245/s10434-013-3376-9. Epub 2013 Nov 20.
6
Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study.基于人工神经网络的肝癌肿瘤分级和微血管侵犯的术前预测:一项初步研究。
J Hepatol. 2010 Jun;52(6):880-8. doi: 10.1016/j.jhep.2009.12.037. Epub 2010 Mar 24.
7
Clinicopathological risk factors for recurrence within one year after initial hepatectomy for hepatocellular carcinoma.肝细胞癌初次肝切除术后一年内复发的临床病理危险因素。
Am Surg. 2011 May;77(5):572-8.
8
Alpha-fetoprotein: the predictor of microvascular invasion in solitary small hepatocellular carcinoma and criterion for anatomic or non-anatomic hepatic resection.甲胎蛋白:孤立性小肝细胞癌微血管侵犯的预测指标及解剖性或非解剖性肝切除的标准
Hepatogastroenterology. 2013 Jun;60(124):825-36. doi: 10.5754/hge121039. Epub 2013 Jan 16.
9
Impact of preoperative fine-needle aspiration cytologic examination on clinical outcome in patients with hepatocellular carcinoma in a tertiary referral center.术前细针穿刺细胞学检查对三级转诊中心肝细胞癌患者临床结局的影响
Arch Surg. 2004 Feb;139(2):193-200. doi: 10.1001/archsurg.139.2.193.
10
Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria.米兰标准范围内乙型肝炎病毒相关性肝细胞癌微血管侵犯风险的术前预测列线图。
JAMA Surg. 2016 Apr;151(4):356-63. doi: 10.1001/jamasurg.2015.4257.

引用本文的文献

1
A serum TNFR2-based model effectively predicates preoperative microvascular invasion and stratifies the tumor recurrence risk in hepatocellular carcinoma.一种基于血清肿瘤坏死因子受体2(TNFR2)的模型可有效预测术前微血管侵犯,并对肝细胞癌的肿瘤复发风险进行分层。
BMC Gastroenterol. 2025 Aug 27;25(1):622. doi: 10.1186/s12876-025-04152-y.
2
Preoperative circulating tumor cells indicate microvascular invasion and dynamical detection indicate the early recurrence of hepatocellular carcinoma.术前循环肿瘤细胞提示微血管侵犯,动态检测提示肝细胞癌早期复发。
BMC Cancer. 2025 Jul 1;25(1):1025. doi: 10.1186/s12885-025-14178-w.
3
Correlation study of 18F-FDG PET/CT metabolic parameters, heterogeneity index, and microvascular invasion, and its nomogram potential in predicting microvascular invasion in liver cancer before liver transplantation.
18F-FDG PET/CT代谢参数、异质性指数与微血管侵犯的相关性研究及其在预测肝癌肝移植术前微血管侵犯中的列线图潜力
Nucl Med Commun. 2025 Jun 24. doi: 10.1097/MNM.0000000000002014.
4
Chinese expert consensus on the diagnosis and treatment of hepatocellular carcinoma with microvascular invasion (2024 edition).肝细胞癌微血管侵犯诊断与治疗中国专家共识(2024年版)
Hepatobiliary Surg Nutr. 2025 Apr 1;14(2):246-266. doi: 10.21037/hbsn-24-359. Epub 2024 Dec 30.
5
Elevated platelet distribution width and diabetes may serve as preoperative predictors of microvascular invasion in primary hepatocellular carcinoma.血小板分布宽度升高和糖尿病可能作为原发性肝细胞癌微血管侵犯的术前预测指标。
J Cancer Res Clin Oncol. 2025 Mar 14;151(3):111. doi: 10.1007/s00432-025-06157-2.
6
A new model based on preoperative AFP, albumin, and tumor burden score for predicting microvascular invasion in early-stage HCC.一种基于术前甲胎蛋白、白蛋白和肿瘤负荷评分预测早期肝癌微血管侵犯的新模型。
Am J Cancer Res. 2024 Oct 15;14(10):4979-4988. doi: 10.62347/ZGRJ7827. eCollection 2024.
7
Deep Neural Network and Radiomics-based Magnetic Resonance Imaging System for Predicting Microvascular Invasion in Hepatocellular Carcinoma.基于深度神经网络和放射组学的磁共振成像系统用于预测肝细胞癌微血管侵犯
J Cancer. 2024 Oct 14;15(19):6223-6231. doi: 10.7150/jca.93712. eCollection 2024.
8
Preoperative evaluation of microvascular invasion in hepatocellular carcinoma with a radiological feature-based nomogram: a bi-centre study.基于放射学特征的列线图对肝细胞癌微血管侵犯的术前评估:一项双中心研究
BMC Med Imaging. 2024 Jan 27;24(1):29. doi: 10.1186/s12880-024-01206-7.
9
The potential of F-FDG PET/CT metabolic parameter-based nomogram in predicting the microvascular invasion of hepatocellular carcinoma before liver transplantation.基于 F-FDG PET/CT 代谢参数的列线图预测肝移植前肝细胞癌微血管侵犯的潜能。
Abdom Radiol (NY). 2024 May;49(5):1444-1455. doi: 10.1007/s00261-023-04166-8. Epub 2024 Jan 24.
10
Estimating Microvascular Invasion in Patients with Resectable Multinodular Hepatocellular Carcinoma by Using Preoperative Contrast-Enhanced MRI: Establishment and Validation of a Risk Score.利用术前对比增强磁共振成像评估可切除性多结节肝细胞癌患者的微血管侵犯:风险评分的建立与验证
J Hepatocell Carcinoma. 2023 Jul 20;10:1143-1156. doi: 10.2147/JHC.S410237. eCollection 2023.